Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

NCCN Task Force Report: Management of Neuropathy in Cancer

(2017) Michael D. Stubblefield et al.   Journal of the National Comprehensive Cancer Network

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy

(2012) Brandi N. Reeves et al.   CANCER

Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

(2011) Andreas A. Argyriou et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Modeling relationships in clinical research using path analysis Part II: evaluating the model

(2011) Margaret F. Clayton et al.   Journal for Specialists in Pediatric Nursing

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

(2011) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With Cancer

(2011) Ellen M. Lavoie Smith et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties

(2010) Kathleen A. Griffith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

(2010) Debra L. Barton et al.   SUPPORTIVE CARE IN CANCER

Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

(2009) Ethan Basch et al.   JNCI-Journal of the National Cancer Institute

Clinical Challenges: Chemotherapy-Induced Peripheral Neuropathy

(2009) Judith A. Paice   Seminars in Oncology Nursing